Navigation Links
One route to malaria drug resistance found
Date:7/24/2014

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious diseases including bacterial infections and tuberculosis.

The study appears July 24 in Nature Communications.

Many organisms, including the parasite that causes malaria, make a class of molecules called isoprenoids, which play multiple roles in keeping organisms healthy, whether plants, animals or bacteria. In malaria, the investigational drug fosmidomycin blocks isoprenoid synthesis, killing the parasite. But over time the drug often becomes less effective.

"In trials testing fosmidomycin, the malaria parasite returned in more than half the children by the end of the study," said senior author Audrey R. Odom, MD, PhD, assistant professor of pediatrics. "We wanted to know how the parasite is getting around the drug. How can it manage to live even though the drug is suppressing these compounds that are necessary for life?"

Fosmidomycin, an antibiotic, is being evaluated against malaria in phase 3 clinical trials in combination with other antimalarial drugs.

Using next-generation sequencing technology, the research team compared the genetics of malaria parasites that responded to the drug to the genetics of malaria parasites that were resistant to it. With this approach, Odom and her colleagues found mutations in a gene called PfHAD1. With dysfunctional PfHAD1, malaria is resistant to fosmidomycin.

"The PfHAD1 protein is completely unstudied," Odom said. "It's a member of a larger family of proteins, and there are almost no biological functions assigned to them."

In malaria parasites, Odom's team showed that the PfHAD1 protein normally slows down the synthesis of isoprenoids. In other words, when present, PfHAD1 is doing the same job as the drug, slowing isoprenoid manufacturing. Si
'/>"/>

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Novel drug candidates offer new route to controlling inflammation
2. Doubling down on heart failure: Researchers discover new route to disease, and drugs to match
3. New roadmap suggests proven routes to ending health disparities
4. A new route for tackling treatment-resistant prostate cancer
5. Auto-immune disease: The viral route is confirmed
6. Federal Safe Routes to School program reduces child injuries by more than 40 percent in New York City
7. Employee Wellness Challenge Get Fit on Route 66 Has New Mobile App, Announces Health Enhancement Systems
8. A circuitous route to therapy resistance
9. Patheon to Host Complimentary Seminar on “Robustness, Reproducibility and Risk Management; the Route to Successful Commercialisation” at Patheon Bourgoin-Jallieu site
10. Jekyll-and-Hyde protein offers a new route to cancer drugs
11. UNC child neurologist finds potential route to better treatments for Fragile X, autism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
One route to malaria drug resistance found
(Date:9/23/2014)... 23, 2014 On September 23, 2014, My ... for an episode. Simmons is the founder of Traveler of ... audience would like to know. At the start of the ... to start this magazine?” Simmons replied by saying, “I had ... In 2005, I quit that and decided to start my ...
(Date:9/23/2014)... The U.S. Pharmacopeial Convention (USP) has submitted ... (WHO) regarding the assignment of Biological Qualifiers (BQ) to ... Expert Group of the Programme of International Nonproprietary Names ... naming of all biologicals that is consistent with existing, ... these drugs. , Hence, USP supports the concept ...
(Date:9/23/2014)... Healthcare Solutions, the parent ... and Modern Medical, today announced the expansion ... with EMPLOYERS®, America's small business insurance specialist®. ... has saved millions of dollars in workers’ ... Since May 2013, Healthcare Solutions has worked ...
(Date:9/23/2014)... 2014 (HealthDay News) -- Fear of losing your job can ... European study. The study involved more than 7,000 employed ... downturn in Europe, the workers answered questions about the respiratory ... their job within two years. More than 100 new ... of whom were women, during the study period. The ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Altec ... and workflow solutions, will be a participating sponsor ... annual Microsoft Dynamics® GP customer conference, from 8:00am ... Meydenbauer Center in Bellevue, Washington. The Resource Group ... overcome challenges during growth and connect disparate ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Airs Episode With the Founder of Traveler of Charleston Magazine 2Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:EMPLOYERS® Expands Pharmacy Services with Healthcare Solutions After Effective Pilot Program 2Health News:EMPLOYERS® Expands Pharmacy Services with Healthcare Solutions After Effective Pilot Program 3Health News:Job Worries Can Raise Asthma Risk, Study Says 2Health News:Altec to Sponsor The Resource Group’s Annual RG Connect Conference 2Health News:Altec to Sponsor The Resource Group’s Annual RG Connect Conference 3
... can be severe , , MONDAY, May 18 (HealthDay News) -- ... as it tries to serve the poor, researchers from North ... recovering from breast cancer do not take the drugs ... do not follow instructions to take these drugs, medications that ...
... CLC 27th Annual Conference on Professional Issues May 24 in ... Council, the leading nonprofit professional association serving child life specialists, ... recipient of the 2009 Distinguished Service Award, in recognition of ... Utica College was selected by ...
... retail locationNORTH BERGEN, N.J., May 18 Eco Shoppe has announced ... Eco Shoppe store in the country. Eco Shoppe is a ... products directly to consumers through exciting new stores as well as ... will open in Austin on May 21 and is owned and ...
... made on May 13, 2009, as Minnesota became the ... health provider into state statute - enabling students who ... model to become licensed to practice. The Minnesota ... a bill establishing the Dental Therapist and Advanced Dental ...
... Study Confirms Previous Positive Findings on Efficacy and ... Deutsche Bank 34th Annual Healthcare Conference Today at ... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... from its Phase IIb clinical trial known as ...
... study finds , , MONDAY, May 18 (HealthDay News) -- People ... chance of living a longer and healthier life. , Researchers ... data from 2002 to 2007, found that that wealthier people ... were less likely to have depression, high-blood pressure or diabetes ...
Cached Medicine News:Health News:Poor Women Seem to Be Skipping Breast Cancer Drugs 2Health News:Utica College to Receive Child Life Council Spirit of Giving Award 2Health News:Utica College to Receive Child Life Council Spirit of Giving Award 3Health News:First Eco Shoppe Opening in Austin on May 21 2Health News:First Eco Shoppe Opening in Austin on May 21 3Health News:First Eco Shoppe Opening in Austin on May 21 4Health News:Minnesota Passes Legislation Allowing Mid-level Oral Health Provider 2Health News:Minnesota Passes Legislation Allowing Mid-level Oral Health Provider 3Health News:Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain 2Health News:Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain 3Health News:Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain 4Health News:Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain 5Health News:Money May Matter, Health-Wise, in Old Age 2
(Date:9/23/2014)... 2014  As physicians seek information about drugs ... to learn about new therapies or ask questions ... new report by global sales and marketing consultants ... via a customized mix of digital media and ... to engage with physicians. And, productive engagement with ...
(Date:9/22/2014)... BARCELONA , España, September 23, 2014 ... nube permite que los patrocinadores de ensayos clínicos satisfagan ... a la accesibilidad y exhaustividad de los expedientes permanentes ... La mayor encuesta sobre TMF en el ... un aumento en el número de patrocinadores de ensayos ...
(Date:9/22/2014)... Calif. , Sept. 22, 2014 Avanir ... that it is offering to sell $200 million of ... Morgan, Deutsche Bank Securities and BofA Merrill Lynch are ... to grant the underwriters a 30-day option to purchase ... shares to be sold in the offering are being ...
Breaking Medicine Technology:As sales reps see doors close for in-person visits with physicians, digital doors open communication 2As sales reps see doors close for in-person visits with physicians, digital doors open communication 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 4As sales reps see doors close for in-person visits with physicians, digital doors open communication 5El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 2El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 3El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 4El acceso remoto al eTMF se duplicará en 2015, revela una encuesta general del sector 5Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... N.J., Oct. 31, 2011 Johnson & Johnson Pharmaceutical ... has submitted a supplemental New Drug Application (sNDA) to ... ® ER (tapentadol) extended-release tablets, an oral analgesic, ... peripheral neuropathy (DPN) in adults. The FDA approved NUCYNTA ...
... NEW YORK, Oct. 31, 2011 Reportlinker.com ... is available in its catalogue: ... 2016 http://www.reportlinker.com/p0254518/Germany-Surgical-Equipment-Market-Outlook-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... to 2016 Summary ...
Cached Medicine Technology:Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 2Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 3Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 4Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 5Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 6Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 7Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 8Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 9Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 10Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 11Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 12Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain 13Germany Surgical Equipment Market Outlook to 2016 2Germany Surgical Equipment Market Outlook to 2016 3Germany Surgical Equipment Market Outlook to 2016 4Germany Surgical Equipment Market Outlook to 2016 5Germany Surgical Equipment Market Outlook to 2016 6Germany Surgical Equipment Market Outlook to 2016 7Germany Surgical Equipment Market Outlook to 2016 8Germany Surgical Equipment Market Outlook to 2016 9
... GE Healthcare is ... in best-in-class analysis programs ... area monitoring device. With ... 12SL, Gender-Specific, and ACI-TIPI, ...
... The Affinity pacemaker family ... smallest, truly automatic devices. ... combination of advanced technologies ... DR pacemaker incorporates the ...
... small bench top chemistry analyzer that utilizes dry ... with results available within 8 - 15 minutes. ... instrument accepts whole blood samples and is calibrated ... At the conclusion of testing, results are available ...
... is a battery-backed up, microprocessor based, quality instrument ... It stores and displays a chart on its ... scrolled through or zoomed into and out of, ... to 3 months can be seen at one ...
Medicine Products: